Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11400164 Immunoconjugates targeting HER2

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
September 2, 2021
0
Date of Patent
August 2, 2022
0
Patent Application Number
17465284
0
Patent Citations
‌
US Patent 10662252 Disease therapy by inducing immune response to Trop-2 expressing cells
‌
US Patent 10744204 Conjugated compounds comprising cysteine-engineered antibodies
‌
US Patent 10744206 Compounds and compositions for immunotherapy
‌
US Patent 10780180 Compounds and compositions for immunotherapy
‌
US Patent 10849984 Immunogenic compound
‌
US Patent 10953073 XTEN conjugate compositions and methods of making same
‌
US Patent 10973826 Antibody conjugates comprising toll-like receptor agonist
‌
US Patent 11046781 Anti-HER2 combinations for treating tumors
‌
US Patent 11053240 2-amino-quinoline derivatives
‌
US Patent 10000539 Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers
•••
Patent Inventor Names
David Y. Jackson
0
Shelley Erin Ackerman
0
Arthur Lee
0
Michael N. Alonso
0
Edgar George Engleman
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11400164
0
Patent Primary Examiner
‌
Daniel C Gamett
0

Find more entities like US Patent 11400164 Immunoconjugates targeting HER2

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo